Edition:
India

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,684.00GBp
9:17pm IST
Change (% chg)

-24.00 (-1.41%)
Prev Close
1,708.00
Open
1,710.00
Day's High
1,710.50
Day's Low
1,678.50
Volume
1,622,729
Avg. Vol
2,063,651
52-wk High
1,738.50
52-wk Low
1,242.50

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip... (more)

Overall

Beta: 0.84
Market Cap(Mil.): £12,228.70
Shares Outstanding(Mil.): 874.88
Dividend: 9.50
Yield (%): --

Financials

BRIEF-Dantax Receives Tender Offer For Its Shares In Opus Acoustics And Ansuz-Acoustics

* SAID ON THURSDAY RECEIVED TENDER OFFER FOR ALL ITS SHARES IN ASSOCIATED COMPANIES, OPUS ACOUSTICS AND ANSUZ-ACOUSTICS

17 May 2019

Nivea-maker Beiersdorf buys Coppertone for $550 million

BERLIN Beiersdorf, the maker of Nivea and other skin care brands, is buying U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its position in North America, the German consumer goods firm said on Monday.

13 May 2019

UPDATE 2-FTSE 100 flounders as miners, exporters drag; Metro Bank plummets

* Metro Bank hits life-low after Q1 results (Adds news items, analyst comment, updates to closing prices)

02 May 2019

Smith & Nephew boosts full-year outlook after Q1 growth

May 2 Medical products maker Smith & Nephew on Thursday forecast annual revenue growth at the top half of its previously estimated range after reporting a 4.4 percent rise in quarterly revenue on an underlying basis.

02 May 2019

Nivea-maker Beiersdorf reports strong first quarter

BERLIN, April 30 German consumer goods firm Beiersdorf reported a strong start to the year on Tuesday on healthy sales of its Nivea skin cream after its new chief executive launched a new strategy to help the firm compete with niche brands.

30 Apr 2019

Deals of the day-Mergers and acquisitions

March 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

13 Mar 2019

Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

12 Mar 2019

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

March 12 Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

12 Mar 2019

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

12 Mar 2019

Smith & Nephew in talks to buy NuVasive for over $3 billion: FT

Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

09 Feb 2019

Earnings vs. Estimates